Author

Lawrence Chang

Observed name: L. Chang

Institution: Astellas Pharma (United States)

Observed institutions: University of Michigan, Gilead Sciences (United States), Astellas Pharma (United States), U-M Rogel Cancer Center, Western University of Health Sciences

ORCID: 0000-0001-9598-2120

Observed ORCIDs: 0000-0001-9598-2120, 0000-0002-2938-5309

OpenAlex ID: A5102915448

Immunotherapies: Exploiting the Immune System for Cancer Treatment

2018 · Jeffrey Koury, Mariana Lucero, et al. · Journal of Immunology Research · 189

Vorinostat plus tacrolimus and mycophenolate to prevent graft-versus-host disease after related-donor reduced-intensity conditioning allogeneic haemopoietic stem-cell transplantation: a phase 1/2 trial

2013 · Sung Won Choi, Thomas Braun, et al. · The Lancet Oncology · 134

Plasma CXCL9 elevations correlate with chronic GVHD diagnosis

2013 · Carrie L. Kitko, John E. Levine, et al. · Blood · 116

Bisphenol-A exposure induced neurotoxicity in glutamatergic neurons derived from human embryonic stem cells

2019 · Hongou Wang, Lawrence Chang, et al. · Environment International · 67

Health-related quality of life in the phase III ASCENT trial of sacituzumab govitecan versus standard chemotherapy in metastatic triple-negative breast cancer

2022 · Sibylle Loibl, Delphine Loirat, et al. · European Journal of Cancer · 56

Microglia-containing cerebral organoids derived from induced pluripotent stem cells for the study of neurological diseases

2023 · Yiling Hong, Xu Dong, et al. · iScience · 49

Targeting Deacetylases as a Novel Strategy for Prevention of Acute GVHD

2013 · Sung Won Choi, Guoqing Hou, et al. · Transplantation and Cellular Therapy · 1

Understanding the symptoms and impacts of living with metastatic pancreatic adenocarcinoma: a prospective, noninterventional qualitative study

2025 · Mok Oh, Lawrence Chang, et al. · The Oncologist

Real-world treatment patterns and outcomes among patients (pts) with second-line (2L) and third-line (3L) metastatic triple-negative breast cancer (mTNBC) in England using the Cancer Analysis System (CAS).

2022 · Lawrence Chang, Peter S. Hall, et al. · Journal of Clinical Oncology

PGI16 A Structured Literature Review of Modelling Approaches for Steroid Use and Treatment Stopping Rules in Ulcerative Colitis for Economic Evaluation

2020 · X. L.U., C. Jones, et al. · Value in Health

Tp3 the Consistency of Us Real-world Rheumatoid Arthritis Disease-modifying Antirheumatic Drug Treatment Patterns With American College of Rheumatology Guidelines

2020 · R.K. Dore, J. Antonova, et al. · Value in Health

Works count: 11

Citation count: 612

H-index: 6

I10-index: 6